Medtronic Drug-Coated Balloon for Peripheral Artery Disease Tops Standard Balloon Angioplasty in Landmark Study
The results of a landmark study published this month in Circulation, the world's leading cardiovascular journal, indicate that a novel medical device from Medtronic, Inc. (NYSE: MDT) called the IN.PACT Admiral drug-coated balloon (DCB) significantly outperformed standard balloon angioplasty in the treatment of symptomatic peripheral artery disease in the upper leg -- specifically, the superficial femoral and proximal popliteal arteries.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news
More News: Angioplasty | Baloon Angioplasty | Cardiology | Cardiovascular | Heart | Medical Devices | Peripheral Vascular Disease (PVD) | Study